Feature Vaccine hesitancy: an interview with Stanley Plotkin, rubella vaccine developer BMJ 2019; 367 doi: https://doi.org/10.1136/bmj.l6926 (Published 23 December 2019) Cite this as: BMJ 2019;367:l6926 Article Related content Metrics Responses Peer review Related articles No related articles found. See more Jeremy Farrar: Make vaccine available to other countries as soon as our most vulnerable people have received it BMJ February 19, 2021, 372 n459; DOI: https://doi.org/10.1136/bmj.n459 Should spreading anti-vaccine misinformation be criminalised? BMJ February 17, 2021, 372 n272; DOI: https://doi.org/10.1136/bmj.n272 Rammya Mathew: “Back to school” must be backed by a functioning covid-19 testing programme BMJ September 17, 2020, 370 m3614; DOI: https://doi.org/10.1136/bmj.m3614 Should countries aim for elimination in the covid-19 pandemic? BMJ September 09, 2020, 370 m3410; DOI: https://doi.org/10.1136/bmj.m3410 Rammya Mathew: Planning for this year’s flu vaccination programme BMJ August 18, 2020, 370 m3180; DOI: https://doi.org/10.1136/bmj.m3180
